Mochida Pharmaceutical Co., Ltd. (MFY.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:37AM CEST. Market open.
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 683.48M |
| Enterprise value | 424.39M |
| Trailing P/E | 36.65 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.14 |
| Price/book (mrq) | 0.88 |
| Enterprise value/revenue | 0.00 |
| Enterprise value/EBITDA | 0.04 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.04 |
| 52-week change 3 | -21.67% |
| S&P500 52-week change 3 | 26.27% |
| 52-week high 3 | 24.80 |
| 52-week low 3 | 18.30 |
| 50-day moving average 3 | 19.01 |
| 200-day moving average 3 | 20.02 |
Share statistics
| Avg vol (3-month) 3 | N/A |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 35.45M |
| Implied shares outstanding 6 | 36.36M |
| Float 8 | 19.98M |
| % held by insiders 1 | 38.13% |
| % held by institutions 1 | 18.92% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.49 |
| Forward annual dividend yield 4 | 2.60% |
| Trailing annual dividend rate 3 | 120.00 |
| Trailing annual dividend yield 3 | 638.30% |
| 5-year average dividend yield 4 | 2.50 |
| Payout ratio 4 | 93.09% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 28 Mar 2024 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 27 Mar 2019 |
Financial highlights
Currency in JPY.Fiscal year
| Fiscal year ends | 31 Mar 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 3.01% |
| Operating margin (ttm) | 6.40% |
Management effectiveness
| Return on assets (ttm) | 1.55% |
| Return on equity (ttm) | 2.34% |
Income statement
| Revenue (ttm) | 100.08B |
| Revenue per share (ttm) | 2,768.28 |
| Quarterly revenue growth (yoy) | 1.90% |
| Gross profit (ttm) | N/A |
| EBITDA | 6.6B |
| Net income avi to common (ttm) | 3.01B |
| Diluted EPS (ttm) | 0.51 |
| Quarterly earnings growth (yoy) | -61.40% |
Balance sheet
| Total cash (mrq) | 43.41B |
| Total cash per share (mrq) | 1,221.87 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 4.39 |
| Book value per share (mrq) | 3,579.89 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.